Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
2.7
2.8
Journals
Healthcare
Special Issues
Innovative Approaches to HPV Vaccination Promotion
share announcement

Innovative Approaches to HPV Vaccination Promotion

A special issue of Healthcare (ISSN 2227-9032).

Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 4182

Special Issue Editor

Prof. Dr. Michael L. Hecht

E-Mail Website
Guest Editor
1. Distinguished Professor Emeritus, Department of Communication Arts and Science, Penn State University, State College, PA 16801, USA
2. President, REAL Prevention LLC, Clifton, NJ 07013, USA
Interests: HPV vaccine promotion; narrative health messages; cultural grounding and multiculturalism; digital health promotion

Special Issue Information

Dear Colleagues,

The COVID-19 pandemic has highlighted the differences between vaccines and vaccination. Effective vaccines can be developed for various diseases (e.g., the COVID-19 vaccines), but unless there is an effective public health strategy for vaccination, the public health benefits will never be fully realized. In fact, almost conversely related to the emergence of new vaccines, an unwillingness to utilize these life-saving strategies, fueled by organized misinformation campaigns, has reduced their effectiveness in conferring resistance to the spread of diseases such as COVID-19, measles, etc. The widely publicized “anti-vax” movement is but one of the challenges to public health that must be overcome if we are to realize the full promise of our growing repertoire of vaccines.

The HPV vaccine provides a perfect illustration of this problem. HPV is the most common sexually transmitted infection (STI) in the U.S. About 80 million people are currently infected with HPV, and approximately 14 million become infected each year. Infection with HPV is associated with virtually all cervical cancers as well as many other anogenital, penile, and oropharyngeal cancers, and has recently been linked to head and neck cancers. HPV costs the U.S.  USD 13.1 billion annually, with lower SES and minority groups, including African American and Latina women, most negatively impacted by HPV-associated diseases. However, despite these clear risks for the unvaccinated, HPV vaccination rates are suboptimal. While rates increased to 60–65% among youth by 2018, these numbers overall are less than desirable and are even lower for youth ages 13 and under, and among minority groups.

This Special Issue will present commentaries, original research papers, and reviews of the issues surrounding HPV vaccine promotion. The articles will highlight new and emerging innovative approaches to vaccine promotion that will have relevance to other public health challenges, including topics such as innovative messaging strategies, tailoring, cultural relevance, and digital messaging.

Prof. Dr. Michael L. Hecht
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • HPV vaccination
  • enhancing cultural relevance
  • tailoring
  • narrative health messages
  • motivational interviewing
  • digital message

Published Papers (3 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Other

9 pages, 219 KiB  
Article
“I’m Torn”: Qualitative Analysis of Dental Practitioner-Perceived Barriers, Facilitators, and Solutions to HPV Vaccine Promotion
by Meghan M. JaKa, Maren S. G. Henderson, Amanda D. Gillesby, Laura J. Zibley, Sarah M. Basile, Bryan S. Michalowicz, Donald Worley, Elyse O. Kharbanda, Steve E. Asche, Patricia L. Mabry and Brad D. Rindal
Healthcare 2024, 12(7), 780; https://doi.org/10.3390/healthcare12070780 - 3 Apr 2024
Viewed by 771
Abstract
The human papillomavirus (HPV) vaccine can prevent HPV-related oropharyngeal cancers. Dental practitioners are uniquely positioned to promote HPV vaccines during routine dental care but experience barriers to doing so. Qualitative interviews were conducted with dental practitioners to understand barriers and inform intervention strategies [...] Read more.
The human papillomavirus (HPV) vaccine can prevent HPV-related oropharyngeal cancers. Dental practitioners are uniquely positioned to promote HPV vaccines during routine dental care but experience barriers to doing so. Qualitative interviews were conducted with dental practitioners to understand barriers and inform intervention strategies to promote HPV vaccines. Dental practitioners were invited to participate in phone interviews about knowledge, self-efficacy, and the fear of negative consequences related to HPV vaccine promotion as well as feedback on potential interventions to address these barriers. Interviews were audio recorded, transcribed, and analyzed using rapid qualitative analysis with a sort-and-sift matrix approach. Interviews were completed with 11 practitioners from six dental clinics (avg. 31 min). Though most thought HPV vaccination was important, they lacked detailed knowledge about when and to whom the vaccine should be recommended. This led to a hypothesized need for discussions of sexual history, feelings of limited self-efficacy to make the recommendation, and fear of patient concerns. Still, practitioners were supportive of additional training opportunities and provided input into specific interventions. The nuance of how these barriers were described by practitioners, as well as the possible solutions they identified, will help shape future interventions supporting HPV vaccine promotion in dental care. Full article
(This article belongs to the Special Issue Innovative Approaches to HPV Vaccination Promotion)
10 pages, 220 KiB  
Article
Disruptions to and Innovations in HPV Vaccination Strategies within Safety-Net Healthcare Settings Resulting from the COVID-19 Pandemic
by Samantha Garcia, Michelle Shin, Kylie Sloan, Emily Dang, Carlos Orellana Garcia, Lourdes Baezconde-Garbanati, Lawrence A. Palinkas, Benjamin F. Crabtree and Jennifer Tsui
Healthcare 2023, 11(17), 2380; https://doi.org/10.3390/healthcare11172380 - 24 Aug 2023
Cited by 1 | Viewed by 1122
Abstract
The COVID-19 pandemic disrupted healthcare delivery within safety-net settings. Barriers to and facilitators of human papillomavirus (HPV) vaccination during the pandemic can inform future HPV vaccine strategies for underserved communities. Qualitative interviews (n = 52) between December 2020 and January 2022 in [...] Read more.
The COVID-19 pandemic disrupted healthcare delivery within safety-net settings. Barriers to and facilitators of human papillomavirus (HPV) vaccination during the pandemic can inform future HPV vaccine strategies for underserved communities. Qualitative interviews (n = 52) between December 2020 and January 2022 in Los Angeles and New Jersey were conducted with providers, clinic leaders, clinic staff, advocates, payers, and policy-level representatives involved in the HPV vaccine process. Using the updated Consolidated Framework for Implementation Research we identified (1) outer setting barriers (i.e., vaccine hesitancy driven by social media, political views during the pandemic) and facilitators (e.g., partnerships); (2) inner setting clinic facilitators (i.e., motivation-driven clinic metrics, patient outreach, vaccine outreach events); (3) individual characteristics such as patient barriers (i.e., less likely to utilize clinic services during the pandemic and therefore, additional outreach to address missed vaccine doses are needed); (4) innovations in HPV vaccination strategies (i.e., clinic workflow changes to minimize exposure to COVID-19, leveraging new community partnerships (e.g., with local schools)); and (5) implementation strategies (i.e., multisectoral commitment to HPV goals). Pandemic setbacks forced safety-net settings to develop new vaccine approaches and partnerships that may translate to new implementation strategies for HPV vaccination within local contexts and communities. Full article
(This article belongs to the Special Issue Innovative Approaches to HPV Vaccination Promotion)

Other

Jump to: Research

12 pages, 282 KiB  
Commentary
Patient–Provider Health Communication Strategies: Enhancing HPV Vaccine Uptake among Adolescents of Color
by Mia Ann Xu, Jasmin Choi, Ariadna Capasso and Ralph DiClemente
Healthcare 2023, 11(12), 1702; https://doi.org/10.3390/healthcare11121702 - 10 Jun 2023
Cited by 1 | Viewed by 1445
Abstract
Cervical cancer remains a public health issue in the United States, particularly among stigmatized racial and ethnic populations. The human papillomavirus (HPV) vaccine has been clinically proven to prevent cervical cancers, and other HPV-associated cancers, among men and women. However, HPV vaccine uptake [...] Read more.
Cervical cancer remains a public health issue in the United States, particularly among stigmatized racial and ethnic populations. The human papillomavirus (HPV) vaccine has been clinically proven to prevent cervical cancers, and other HPV-associated cancers, among men and women. However, HPV vaccine uptake is suboptimal; only 55% of adolescents complete the two-dose series by age 15. Past research has shown that provider HPV vaccine communication for people of marginalized races/ethnicities is subpar. This article focuses on provider communication strategies to promote HPV vaccine uptake effectively and equitably. The authors reviewed the literature on evidence-based patient–provider HPV vaccine communication techniques to create a set of communication language providers could use and avoid using to enhance HPV vaccine acceptance and uptake among adolescents of marginalized racial and ethnic groups. Evidence has shown that information and the manner of dissemination are critical for influencing HPV vaccine uptake. These communication strategies must be suited to the context of the targeted population, and the message content can be broadly categorized into source, content, and modality. Strategies to improve patient–provider communication among adolescents of color using source, modality, and content include the following: (1) Source: increase provider self-efficacy to provide the recommendation, building rapport between providers and parents; (2) Content: persistent, forceful language with minimal acquiescence should be employed, reframing the conversation focus from sex to cancer; and (3) Modality: use multiple vaccine reminder modalities, and work with the community to culturally adapt the vaccination language. Utilizing effective behavior-change communication adapted for adolescents of color can reduce missed opportunities for HPV prevention, potentially decreasing racial and ethnic disparities in HPV-related morbidity and mortality. Full article
(This article belongs to the Special Issue Innovative Approaches to HPV Vaccination Promotion)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-3
Back to TopTop